CN101214278A - New raw material for extracting total lignans from Schisandra chinensis, preparation process and application - Google Patents
New raw material for extracting total lignans from Schisandra chinensis, preparation process and application Download PDFInfo
- Publication number
- CN101214278A CN101214278A CNA2007101591969A CN200710159196A CN101214278A CN 101214278 A CN101214278 A CN 101214278A CN A2007101591969 A CNA2007101591969 A CN A2007101591969A CN 200710159196 A CN200710159196 A CN 200710159196A CN 101214278 A CN101214278 A CN 101214278A
- Authority
- CN
- China
- Prior art keywords
- schisandra
- gomisin
- extract
- schisandra chinensis
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于医药技术领域,公开了五味子总木脂素提取物的新原料及其制备工艺。该工艺以中药五味子果梗(果柄)和五味子叶为原料,粉碎后采用溶剂提取法、树脂吸附法、正相柱层析法、反相柱层析法等工艺中的一种或者多种工艺,制备成总木脂素含量为30-95%的提取物。该制备方法工艺简单,含量稳定,重现性好。此提取物能替代五味子果实总木脂素提取物入药或入健康食品,充分利用五味子资源,缓解五味子果实供不应求的状况。The invention belongs to the technical field of medicine, and discloses a new raw material of a total lignan extract of schisandra chinensis and a preparation process thereof. The process uses the Chinese medicine Schisandra schisandra fruit stem (carp) and Schisandra cotyledon leaves as raw materials, and adopts one or more of processes such as solvent extraction, resin adsorption, normal phase column chromatography, and reverse phase column chromatography after crushing. process to prepare an extract with a total lignan content of 30-95%. The preparation method has the advantages of simple process, stable content and good reproducibility. The extract can replace the total lignan extract of schisandra fruit and be used as medicine or health food, make full use of schisandra resources, and alleviate the situation that the supply of schisandra fruit is in short supply.
Description
技术领域technical field
本发明属于医药技术领域,涉及五味子总木脂素提取物的新原料及其制备工艺。根据该制备工艺所得的提取物,其木脂素类化合物的总含量在30-95%。用于预防和治疗肝炎。The invention belongs to the technical field of medicine, and relates to a new raw material of Schisandra chinensis total lignan extract and a preparation process thereof. The extract obtained according to the preparation process has a total content of lignans in 30-95%. For the prevention and treatment of hepatitis.
背景技术Background technique
五味子的脂溶性活性成分主要为木脂素。其药理作用涉及消化系统、心血管系统、中枢神经系统、生殖系统以及抗氧化、抗衰老等各个方面(中药材2005年2月第28卷第2期)。The fat-soluble active ingredients of Schisandra chinensis are mainly lignans. Its pharmacological effects involve various aspects such as digestive system, cardiovascular system, central nervous system, reproductive system, anti-oxidation and anti-aging (Chinese herbal medicine, volume 28, phase 2, February 2005).
五味子叶及五味子果梗(果柄)是木兰科五味子属植物北五味子Schisandra chinensis(Turcz.)Baill.、华中五味子Schisandrasphenanthera Rehd.et Wils.及五味子属其他植物的干燥叶及果梗(果柄)。Schisandra chinensis (Turcz.) Baill., Schisandra chinensis (Turcz.) Baill., Schisandra sphenanthera Rehd.et Wils. and other plants of the genus Schisandra. .
国外学者应用高效液相色谱仪对五味子叶的CO2超临界提取物进行分析,发现其含有和五味子果实相同的木脂素,如五味子醇甲、醇乙、甲素、乙素、丙素和gomisin N等(Journal of Chromatography B,770(2002)283289)。五味子果梗(果柄)中含有与五味子果实相同的木脂素,如五味子醇甲、酯甲、甲素、乙素等(延边大学医学学报2005年3月第28卷第1期)。Foreign scholars used high-performance liquid chromatography to analyze the CO 2 supercritical extract of Schisandra leaves, and found that it contained the same lignans as Schisandra fruit, such as Schizandrin A, Alcohol B, A, B, C and gomisin N et al. (Journal of Chromatography B, 770 (2002) 283289). Schisandra fruit stem (stalk) contains the same lignans as Schisandra fruit, such as schisandrin A, ester A, A, B, etc. (Medical Journal of Yanbian University, March 2005, Volume 28, No. 1).
目前,五味子市场需求量很大,远远满足不了国内外市场的要求,出现了对野生资源灭绝性的割蔓采收和破坏,有的地区普遍出现掠青现象,使五味子资源受到不同程度的破坏,导致可利用的五味子的资源减少,质量下降,价格不断攀升。五味子果实成熟时果实与果梗(果柄)一起从五味子藤上采摘下来,而果梗(果柄)作为杂质被剔除,而五味子叶资源更是十分丰富,如果能将五味子叶及果梗(果柄)作为五味子木脂素来源的补充,将能够充分利用资源,变废为宝。At present, the market demand for Schisandra chinensis is very large, which is far from meeting the requirements of domestic and foreign markets. Extinct vine harvesting and destruction of wild resources have occurred, and the phenomenon of plundering greens has generally occurred in some areas, which has caused Schisandra chinensis resources to be affected to varying degrees. Destruction, resulting in the reduction of available Schisandra resources, quality decline, and rising prices. When the fruit of Schisandra chinensis is ripe, the fruit and the fruit stem (stalk) are picked together from the vine of Schisandra vine, and the fruit stem (stalk) is removed as impurities, and the resource of Schisandra leaves is very rich. If the leaves and stems ( fruit stalk) as a supplement to the source of Schisandra lignans will be able to make full use of resources and turn waste into treasure.
发明内容Contents of the invention
本发明的目的是针对上述五味子药材紧缺的情况提供五味子总木脂素的两种新来源,两种五味子果梗(果柄)及叶总木脂素提取物的制备工艺,以及依据该工艺制备而得的提取物及其相关剂型。作为五味子资源的补充,替代五味子果实总木脂素提取物入药或健康食品。The object of the present invention is to provide two new sources of total lignans of Schisandra chinensis in view of the shortage of above-mentioned Schisandra medicinal materials, the preparation process of two kinds of Schisandra fruit stem (stalk) and leaf total lignan extracts, and the preparation process according to the process The obtained extract and related dosage forms thereof. As a supplement to Schisandra chinensis resources, it can be used as medicine or health food instead of the total lignan extract of Schisandra chinensis fruit.
本发明是通过如下技术方案完成的:The present invention is accomplished through the following technical solutions:
(1)将五味子叶、果梗(果柄)干燥,粉碎,水煮;将水提取后残渣干燥,用50~95%的甲醇、乙醇、异丙醇或正丁醇的一种加热回流提取,提取液减压浓缩为密度0.80-1.20的浓缩液;采用大孔吸附树脂柱富集,用水,40%~75%乙醇,95%乙醇洗脱,收集95%乙醇洗脱液,浓缩后得到的提取物,其总木脂素重量含量为30%-95%。(1) Dry Schisandra leaves and fruit stems (fruit stalks), crush them, boil them in water; dry the residue after water extraction, and extract with 50-95% methanol, ethanol, isopropanol or n-butanol under reflux , the extract is concentrated under reduced pressure to a concentrated solution with a density of 0.80-1.20; it is enriched by a macroporous adsorption resin column, eluted with water, 40% to 75% ethanol, and 95% ethanol, and the 95% ethanol eluate is collected and concentrated to obtain The extract of the invention has a total lignan weight content of 30%-95%.
(2)将五味子叶、果梗(果柄)干燥,粉碎,水煮;将水提取后残渣干燥,用70~95%的甲醇、乙醇、异丙醇或正丁醇的一种加热回流提取,提取液减压浓缩至干,有机溶剂室温或加热回流提取,提取物采用色谱柱洗脱,洗脱后得到的提取物,其总木脂素重量含量为30%-95%。(2) Dry the Schisandra cotyledon and fruit stem (fruit stalk), pulverize, and boil in water; dry the residue after water extraction, and extract with 70-95% methanol, ethanol, isopropanol or n-butanol under reflux The extract is concentrated to dryness under reduced pressure, extracted with an organic solvent at room temperature or heated to reflux, and the extract is eluted with a chromatographic column, and the total lignan weight content of the extract obtained after elution is 30%-95%.
依据以上工艺制备而得的总木脂素提取物含有化合物:五味子醇甲、醇乙、甲素、乙素、丙素和gomisin G、gomisinL1、gomisinM1、gomisinN等。此提取物可以和药学上可以接受的载体混合,制成各种临床可用的剂型。The total lignan extract prepared according to the above process contains compounds: schisandrin A, alcohol B, A, B, C, gomisin G, gomisinL 1 , gomisinM 1 , gomisinN and the like. The extract can be mixed with pharmaceutically acceptable carriers to make various clinically available dosage forms.
本发明的有益效果Beneficial effects of the present invention
本发明针对替代五味子果实总木脂素提取物入药或入健康食品,充分利用五味子资源,缓解五味子果实供不应求的状况。The invention aims at replacing the total lignan extract of schisandra fruit as medicine or health food, making full use of schisandra resources, and alleviating the situation that the supply of schisandra fruit is in short supply.
具体实施方式Detailed ways
下面的实施例可进一步说明本发明,但不以任何方式限制本发明。The following examples further illustrate the invention but do not limit it in any way.
实施例1:Example 1:
北五味子叶2Kg,粉碎,加水回流提取两次,每次保持微沸状态1.5小时,过滤,弃去合并的滤液。残渣晾干后,加入14L80%乙醇,加热回流提取3次,每次2小时,过滤,合并滤液并减压浓缩,得密度为0.93的浓缩液610g。用大孔吸附树脂柱富集,分别用水,60%乙醇,90%乙醇梯度洗脱,收集90%乙醇洗脱液,减压回收乙醇,再次用大孔吸附树脂柱富集,分别用水,75%乙醇,90%乙醇洗脱,收集90%乙醇洗脱液,减压回收乙醇得到15g提取物。总木脂素含量60%。Schisandra schisandra leaves 2Kg, pulverized, refluxed with water to extract twice, each time kept in a slightly boiling state for 1.5 hours, filtered, and the combined filtrate was discarded. After the residue was dried, 14L of 80% ethanol was added, extracted under reflux for 3 times, each time for 2 hours, filtered, and the filtrates were combined and concentrated under reduced pressure to obtain 610 g of a concentrated solution with a density of 0.93. Enriched with a macroporous adsorption resin column, gradient eluted with water, 60% ethanol, and 90% ethanol respectively, collected the 90% ethanol eluate, recovered ethanol under reduced pressure, enriched with a macroporous adsorption resin column again, and used water, 75% ethanol respectively. % ethanol, eluting with 90% ethanol, collecting the 90% ethanol eluate, recovering ethanol under reduced pressure to obtain 15 g of extract. The total lignan content is 60%.
实施例2:Example 2:
北五味子叶2Kg,粉碎,加水回流提取两次,每次保持微沸状态1.5小时,过滤,弃去合并的滤液。残渣晾干后,加入14L80%乙醇,加热回流提取3次,每次2小时,过滤,合并滤液并减压回收乙醇得到干浸膏130g。用石油醚回流提取3次,合并提取液,减压浓缩至小体积10ml,通过硅胶柱层析富集,用石油醚∶乙酸乙酯(20∶1)洗脱后,再用石油醚∶乙酸乙酯(2∶1)洗脱,收集石油醚∶乙酸乙酯(2∶1)洗脱液,减压浓缩得到10g提取物。总木脂素含量65%。Schisandra schisandra leaves 2Kg, pulverized, refluxed with water to extract twice, each time kept in a slightly boiling state for 1.5 hours, filtered, and the combined filtrate was discarded. After the residue was dried, 14L of 80% ethanol was added, heated and refluxed for 3 times, each time for 2 hours, filtered, the filtrates were combined, and the ethanol was recovered under reduced pressure to obtain 130 g of dry extract. Reflux extraction with petroleum ether for 3 times, combine the extracts, concentrate under reduced pressure to a small volume of 10ml, enrich through silica gel column chromatography, elute with petroleum ether: ethyl acetate (20:1), then use petroleum ether: acetic acid Ethyl ester (2:1) was eluted, and petroleum ether: ethyl acetate (2:1) eluate was collected and concentrated under reduced pressure to obtain 10 g of extract. The total lignan content is 65%.
实施例3:Example 3:
北五味子果梗(果柄)2Kg,粉碎,加水回流提取两次,每次保持微沸状态1.5小时,过滤,弃去合并的滤液。残渣晾干后,加入12L90%乙醇,加热回流提取3次,每次2小时,过滤,合并滤液并减压浓缩,得密度为0.91的浓缩液650g。用大孔吸附树脂柱富集,分别用水,70%乙醇,90%乙醇梯度洗脱,收集90%乙醇洗脱液,减压回收乙醇得到20g提取物。总木脂素含量63%。Schisandra schisandra fruit stem (stalk) 2Kg, pulverized, added water and refluxed for extraction twice, each time kept in a slightly boiling state for 1.5 hours, filtered, and the combined filtrate was discarded. After the residue was dried, 12L of 90% ethanol was added, heated and refluxed for 3 times for 2 hours each time, filtered, and the filtrates were combined and concentrated under reduced pressure to obtain 650 g of a concentrated solution with a density of 0.91. Enriched with a macroporous adsorption resin column, gradient eluted with water, 70% ethanol, and 90% ethanol respectively, collected 90% ethanol eluate, recovered ethanol under reduced pressure to obtain 20 g of extract. The total lignan content is 63%.
实施例4:Example 4:
北五味子果梗(果柄)2Kg,粉碎,加水回流提取两次,每次保持微沸状态1.5小时,过滤,弃去合并的滤液。残渣晾干后,加入12L90%乙醇,加热回流提取3次,每次2小时,过滤,合并滤液并减压回收乙醇得到干浸膏150g。用石油醚回流提取3次,合并提取液,减压浓缩至小体积10ml,通过硅胶柱层析富集,用石油醚∶乙酸乙酯(20∶1)洗脱后,再用石油醚∶乙酸乙酯(2∶1)洗脱,收集石油醚∶乙酸乙酯(2∶1)洗脱液,减压浓缩得到15g提取物。总木脂素含量70%。Schisandra schisandra fruit stem (stalk) 2Kg, pulverized, added water and refluxed for extraction twice, each time kept in a slightly boiling state for 1.5 hours, filtered, and the combined filtrate was discarded. After the residue was dried, 12L of 90% ethanol was added, heated and refluxed for 3 times for 2 hours each time, filtered, the filtrates were combined and the ethanol was recovered under reduced pressure to obtain 150 g of dry extract. Reflux extraction with petroleum ether for 3 times, combine the extracts, concentrate under reduced pressure to a small volume of 10ml, enrich through silica gel column chromatography, elute with petroleum ether: ethyl acetate (20:1), then use petroleum ether: acetic acid Ethyl ester (2:1) was eluted, and petroleum ether: ethyl acetate (2:1) eluate was collected and concentrated under reduced pressure to obtain 15 g of extract. The total lignan content is 70%.
实施例5:Example 5:
北五味子果梗(果柄)2Kg,粉碎,加水回流提取两次,每次保持微沸状态1.5小时,过滤,弃去合并的滤液。残渣晾干后,加入12L90%乙醇,加热回流提取3次,每次2小时,过滤,合并滤液并减压回收乙醇得到干浸膏150g。用石油醚回流提取3次,合并提取液,减压浓缩至小体积10ml,硅胶柱层析,用石油醚∶乙酸乙酯(100∶1~1∶100)梯度洗脱后,合并相同组分洗脱物,再经ODS柱、高效液相(HPLC)、重结晶等方法纯化,得到了五味子醇甲、醇乙、甲素、乙素、丙素、gomisin G、gomisinL1、gomisinM1、gomisinN等25个化合物。并运用核磁共振(NMR)、质谱(MS)、红外(IR)等光谱手段确定了它们的结构。Schisandra schisandra fruit stem (stalk) 2Kg, pulverized, added water to reflux to extract twice, each time kept in a slightly boiling state for 1.5 hours, filtered, and the combined filtrate was discarded. After the residue was dried, 12L of 90% ethanol was added, heated and refluxed for 3 times for 2 hours each time, filtered, the filtrates were combined and the ethanol was recovered under reduced pressure to obtain 150 g of dry extract. Reflux extraction with petroleum ether for 3 times, combine the extracts, concentrate under reduced pressure to a small volume of 10ml, perform silica gel column chromatography, use petroleum ether: ethyl acetate (100:1 ~ 1:100) gradient elution, combine the same components The eluate was purified by ODS column, high performance liquid phase (HPLC), recrystallization and other methods to obtain schisandra alcohol A, alcohol B, A, B, C, gomisin G, gomisinL 1 , gomisinM 1 , gomisinN and so on for 25 compounds. And the use of nuclear magnetic resonance (NMR), mass spectrometry (MS), infrared (IR) and other spectral means to determine their structures.
实施例6:Embodiment 6:
将实施例1、2所得到的五味子叶总木脂素提取物经薄层色谱、高效液相(HPLC)与实施例5中所得到的化合物进行比较,显示其含有五味子醇甲、醇乙、甲素、乙素、丙素、gomisinL1、gomisinM1、gomisinN等14种木脂素。The Schizandra leaf total lignan extract obtained in Examples 1 and 2 is compared with the compound obtained in Example 5 through thin layer chromatography and high performance liquid phase (HPLC), showing that it contains Schisandrin A, alcohol B, A, B, C, gomisinL 1 , gomisinM 1 , gomisinN and other 14 kinds of lignans.
实施例7:Embodiment 7:
北五味子果梗(果柄)2Kg,粉碎,加水回流提取两次,每次保持微沸状态1.5小时,过滤,弃去合并的滤液。残渣晾干后,加入12L90%乙醇,加热回流提取3次,每次2小时,过滤,合并滤液并减压浓缩,得密度为0.91的浓缩液650g。用大孔吸附树脂柱富集,分别用水,70%乙醇,90%乙醇梯度洗脱,收集90%乙醇洗脱液,减压回收乙醇得到20g提取物。总木脂素含量63%。加入4g淀粉,混匀,80%乙醇制粒,干燥,加入硬脂酸镁0.3g,混匀,装入1号胶囊,即得本发明制得的硬胶囊剂70粒。每粒含内容物0.3g。Schisandra schisandra fruit stem (stalk) 2Kg, pulverized, added water and refluxed for extraction twice, each time kept in a slightly boiling state for 1.5 hours, filtered, and the combined filtrate was discarded. After the residue was dried, 12L of 90% ethanol was added, heated and refluxed for 3 times for 2 hours each time, filtered, and the filtrates were combined and concentrated under reduced pressure to obtain 650 g of a concentrated solution with a density of 0.91. Enriched with a macroporous adsorption resin column, gradient eluted with water, 70% ethanol, and 90% ethanol respectively, collected 90% ethanol eluate, recovered ethanol under reduced pressure to obtain 20 g of extract. The total lignan content is 63%. Add 4g of starch, mix evenly, granulate with 80% ethanol, dry, add 0.3g of magnesium stearate, mix evenly, pack into No. 1 capsule, and obtain 70 hard capsules prepared by the present invention. Each capsule contains 0.3g of content.
实施例8:五味子总木脂素提取物对四氯化碳肝损伤小鼠的治疗作用Example 8: Therapeutic effect of Schisandra chinensis total lignans extract on carbon tetrachloride liver injury mice
取小鼠50只,随机分成5组,分别为正常对照组、四氯化碳(CCl4)模型组、五味子果实总木脂素提取物组、实施例1提取物组和实施例3提取物组。Take 50 mice and randomly divide them into 5 groups, which are normal control group, carbon tetrachloride (CCl 4 ) model group, Schisandra fruit total lignans extract group, Example 1 extract group and Example 3 extract group. Group.
其中五味子果实总木脂素提取物的制备方法如下:北五味子果实粉碎,加水回流提取两次,每次保持微沸状态1.5小时,过滤,弃去合并的滤液。残渣晾干后,加入90%乙醇,加热回流提取3次,每次2小时,过滤,合并滤液并减压浓缩,浓缩液用大孔吸附树脂柱富集,分别用水,40%乙醇,90%乙醇梯度洗脱,收集90%乙醇洗脱液,减压回收乙醇,减压回收乙醇得到总木脂素含量70%的提取物。The preparation method of the total lignan extract of Schisandra fruit is as follows: crush the fruit of Schisandra chinensis, add water to reflux and extract twice, keep a slight boiling state for 1.5 hours each time, filter, and discard the combined filtrate. After the residue is dried, add 90% ethanol, heat and reflux to extract 3 times, each time for 2 hours, filter, combine the filtrate and concentrate under reduced pressure, the concentrated solution is enriched with a macroporous adsorption resin column, water, 40% ethanol, 90% Gradient elution with ethanol, collecting 90% ethanol eluate, recovering ethanol under reduced pressure, and recovering ethanol under reduced pressure to obtain an extract with a total lignan content of 70%.
动物实验方法如下:除正常对照组外,每组第一天腹腔注射0.1%CCl4石蜡油溶液(10ml/kg),同时连续灌胃给药7天,末次给药后16小时眼眶取血,测血清谷丙转氨酶(SGPT)。The animal experiment method is as follows: except the normal control group, each group was intraperitoneally injected with 0.1% CCl 4 paraffin oil solution (10ml/kg) on the first day, and administered by intragastric administration for 7 days continuously at the same time, and blood was taken from the orbit 16 hours after the last administration. Serum alanine aminotransferase (SGPT) was measured.
实验结果见下表:The experimental results are shown in the table below:
结论:CCl4组小鼠SGPT显著高于正常对照组(P<0.01);与CCl4组相比,五味子果实总木脂素提取物组、实施例1提取物组、实施例3提取物组SGPT均显著降低(P<0.01);五味子果实总木脂素提取物组、实施例1提取物组、实施例3提取物组之间差异均无显著性意义(P>0.05)。说明五味子果梗(果柄)及叶总木脂素提取物与五味子果实总木脂素提取物对四氯化碳肝损伤小鼠的治疗作用相当,均对四氯化碳肝损伤小鼠导致的SGPT升高有显著的抑制作用。Conclusion: the SGPT of mice in the CCl4 group was significantly higher than that of the normal control group (P<0.01); Significantly decreased (P<0.01); there was no significant difference among the Schisandra fruit total lignans extract group, the extract group of Example 1, and the extract group of Example 3 (P>0.05). It shows that the total lignan extracts of Schisandra fruit stem (carpone) and leaves and the total lignan extracts of Schisandra fruit have similar therapeutic effects on mice with carbon tetrachloride liver injury, and both have the same effect on mice with carbon tetrachloride liver injury. Elevated SGPT has a significant inhibitory effect.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101591969A CN101214278B (en) | 2007-12-26 | 2007-12-26 | New raw material for extracting fructus schizandrae total lignans and preparation technique and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101591969A CN101214278B (en) | 2007-12-26 | 2007-12-26 | New raw material for extracting fructus schizandrae total lignans and preparation technique and use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101214278A true CN101214278A (en) | 2008-07-09 |
CN101214278B CN101214278B (en) | 2012-06-27 |
Family
ID=39620826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101591969A Expired - Fee Related CN101214278B (en) | 2007-12-26 | 2007-12-26 | New raw material for extracting fructus schizandrae total lignans and preparation technique and use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101214278B (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101786945A (en) * | 2009-12-28 | 2010-07-28 | 大兴安岭科丽尔生物工程有限责任公司 | Method for enriching and purifying schizandrol A in schisandra |
CN101978990A (en) * | 2010-09-30 | 2011-02-23 | 曹云峰 | Schisandra extract and preparation method and application thereof |
CN102050707A (en) * | 2009-11-01 | 2011-05-11 | 桂林莱茵生物科技股份有限公司 | Method for extracting deoxyschisandrin and schisandrin B from schisandra |
CN102302554A (en) * | 2011-09-15 | 2012-01-04 | 哈尔滨仁皇药业股份有限公司 | Extraction method of schisandra total lignans |
CN101720964B (en) * | 2009-12-02 | 2012-05-23 | 长白朝鲜族自治县松云野生经济植物有限责任公司 | Schisandra chinensis health-care beverage |
CN102731271A (en) * | 2011-12-25 | 2012-10-17 | 大兴安岭林格贝有机食品有限责任公司 | New method for purifying schisandrin |
CN103141833A (en) * | 2013-02-04 | 2013-06-12 | 北华大学 | Health food with anti-aging effect and preparation method thereof |
CN103751184A (en) * | 2014-01-09 | 2014-04-30 | 广东药学院 | Application of pregnane X receptor antagonist in preparation of lipid regulation and liver protection product |
CN103848809A (en) * | 2012-11-30 | 2014-06-11 | 沈阳药科大学 | Dibenzocyclooctene lignans, microbial conversion products thereof and applications of the microbial conversion products |
CN105477153A (en) * | 2014-08-01 | 2016-04-13 | 卢比肯股份有限公司 | Adaptogenic compositions and method for production thereof |
CN106177119A (en) * | 2016-07-18 | 2016-12-07 | 南京正宽医药科技有限公司 | A kind of Fructus Schisandrae Chinensis granule and preparation method thereof |
CN106266168A (en) * | 2016-08-30 | 2017-01-04 | 扬子江药业集团南京海陵药业有限公司 | A kind of preparation method of Fructus Schisandrae Sphenantherae lignanoid extract |
CN107126460A (en) * | 2017-04-12 | 2017-09-05 | 西安医学院 | A kind of preparation method of fructus schizandrae total lignans |
CN107468803A (en) * | 2017-07-27 | 2017-12-15 | 磐安县派普特生物科技有限公司 | The preparation method of shizandra active extract |
CN107513008A (en) * | 2017-07-27 | 2017-12-26 | 浦江县美泽生物科技有限公司 | Shizandra active extract |
US10159268B2 (en) | 2013-02-08 | 2018-12-25 | General Mills, Inc. | Reduced sodium food products |
CN111875483A (en) * | 2020-08-25 | 2020-11-03 | 长春工业大学 | Method for extracting lignans compounds from schisandra chinensis |
WO2022143252A1 (en) * | 2020-12-29 | 2022-07-07 | 云南生物谷药业股份有限公司 | Preparation method for pharmaceutical composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100363318C (en) * | 2005-02-08 | 2008-01-23 | 朱萧俊 | Extraction of schizandrol A |
-
2007
- 2007-12-26 CN CN2007101591969A patent/CN101214278B/en not_active Expired - Fee Related
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102050707A (en) * | 2009-11-01 | 2011-05-11 | 桂林莱茵生物科技股份有限公司 | Method for extracting deoxyschisandrin and schisandrin B from schisandra |
CN101720964B (en) * | 2009-12-02 | 2012-05-23 | 长白朝鲜族自治县松云野生经济植物有限责任公司 | Schisandra chinensis health-care beverage |
CN101786945A (en) * | 2009-12-28 | 2010-07-28 | 大兴安岭科丽尔生物工程有限责任公司 | Method for enriching and purifying schizandrol A in schisandra |
CN101786945B (en) * | 2009-12-28 | 2014-01-01 | 大兴安岭科丽尔生物工程有限责任公司 | Method for enriching and purifying schizandrol A in schisandra |
CN101978990A (en) * | 2010-09-30 | 2011-02-23 | 曹云峰 | Schisandra extract and preparation method and application thereof |
CN101978990B (en) * | 2010-09-30 | 2013-06-05 | 曹云峰 | Schisandra extract and preparation method and application thereof |
CN102302554B (en) * | 2011-09-15 | 2013-08-07 | 哈尔滨仁皇药业股份有限公司 | Extraction method of schisandra total lignans |
CN102302554A (en) * | 2011-09-15 | 2012-01-04 | 哈尔滨仁皇药业股份有限公司 | Extraction method of schisandra total lignans |
CN102731271B (en) * | 2011-12-25 | 2014-11-19 | 大兴安岭林格贝有机食品有限责任公司 | New method for purifying schisandrin |
CN102731271A (en) * | 2011-12-25 | 2012-10-17 | 大兴安岭林格贝有机食品有限责任公司 | New method for purifying schisandrin |
CN103848809A (en) * | 2012-11-30 | 2014-06-11 | 沈阳药科大学 | Dibenzocyclooctene lignans, microbial conversion products thereof and applications of the microbial conversion products |
CN103141833A (en) * | 2013-02-04 | 2013-06-12 | 北华大学 | Health food with anti-aging effect and preparation method thereof |
US11540539B2 (en) | 2013-02-08 | 2023-01-03 | General Mills, Inc. | Reduced sodium food products |
US10159268B2 (en) | 2013-02-08 | 2018-12-25 | General Mills, Inc. | Reduced sodium food products |
CN103751184A (en) * | 2014-01-09 | 2014-04-30 | 广东药学院 | Application of pregnane X receptor antagonist in preparation of lipid regulation and liver protection product |
CN105477153B (en) * | 2014-08-01 | 2019-11-29 | 卢比肯股份有限公司 | Adapt to former composition and its production method |
CN105477153A (en) * | 2014-08-01 | 2016-04-13 | 卢比肯股份有限公司 | Adaptogenic compositions and method for production thereof |
CN106177119A (en) * | 2016-07-18 | 2016-12-07 | 南京正宽医药科技有限公司 | A kind of Fructus Schisandrae Chinensis granule and preparation method thereof |
CN106266168A (en) * | 2016-08-30 | 2017-01-04 | 扬子江药业集团南京海陵药业有限公司 | A kind of preparation method of Fructus Schisandrae Sphenantherae lignanoid extract |
CN107126460A (en) * | 2017-04-12 | 2017-09-05 | 西安医学院 | A kind of preparation method of fructus schizandrae total lignans |
CN107468803A (en) * | 2017-07-27 | 2017-12-15 | 磐安县派普特生物科技有限公司 | The preparation method of shizandra active extract |
CN107513008A (en) * | 2017-07-27 | 2017-12-26 | 浦江县美泽生物科技有限公司 | Shizandra active extract |
CN111875483A (en) * | 2020-08-25 | 2020-11-03 | 长春工业大学 | Method for extracting lignans compounds from schisandra chinensis |
CN111875483B (en) * | 2020-08-25 | 2022-11-29 | 长春工业大学 | Method for extracting lignanoid compounds from schisandra chinensis |
WO2022143252A1 (en) * | 2020-12-29 | 2022-07-07 | 云南生物谷药业股份有限公司 | Preparation method for pharmaceutical composition |
Also Published As
Publication number | Publication date |
---|---|
CN101214278B (en) | 2012-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101214278B (en) | New raw material for extracting fructus schizandrae total lignans and preparation technique and use | |
TWI330087B (en) | The use of wenguanguo (xanthoceras sorbifolia) saponins for the manufacture of medicament for activating brain function, mehods for preparing saponins and medical compositions thereof | |
KR20120123064A (en) | Pharmaceutical composition including sunflower extract, preparative method and use thereof | |
CN102274244A (en) | Cassia bark polyphenol extract and preparation method and application thereof | |
CN110478398A (en) | A kind of pair of alcoholic liver injury has the Chinese medicine composition and preparation method of defencive function | |
CN102283913A (en) | Radix aconiti carmichaeli extract and application thereof | |
CN100534461C (en) | Pharmaceutical composition for treating diabetes and impaired glucose tolerance and preparation method thereof | |
CN111000903A (en) | Traditional Chinese medicine composition for treating blood stasis type coronary heart disease angina and preparation method thereof | |
CN105832814A (en) | General flavone with effect of treating diabetic mellitus, as well as preparation method and application thereof | |
CN1781516A (en) | Method for preparing piper laetispicum extract, extract and its use | |
CN101822705A (en) | Total platycodin and application of monomer platycodin D in antialcoholic drugs | |
CN116138455A (en) | Panax notoginseng polysaccharide extract and its application in the preparation of anti-fatigue products | |
CN110123859B (en) | Chrysanthemum leaf extract for preventing and treating liver injury and its application | |
CN102258587B (en) | Preparation method and application of red paeony root active ingredient | |
CN103301256A (en) | Preparation method of medicinal plant extract being capable of reducing blood fat and application thereof in pharmacy and health food | |
CN102670711A (en) | White flower salviae miltiorrhizae extract for curing angiitis, preparation method and application | |
CN100428942C (en) | Heart-nourishing and nerve-soothing medicine and preparation method thereof | |
CN113679759A (en) | Application of a safflower seed extract in the preparation of a drug for preventing or treating non-alcoholic fatty liver disease | |
CN101269123A (en) | Secondary development novel technique for thirst eliminating capsule for lowering blood sugar | |
CN111920799A (en) | Kulecuo effective component composition and preparation method and application thereof | |
CN114432411B (en) | A traditional Chinese medicine composition for treating chronic kidney disease proteinuria, its preparation method and application | |
CN116509921B (en) | Application of rice flower sesterterpene extract K01 in preparation of medicines for treating sepsis | |
CN103784623A (en) | Preparation method of medicinal plant extract for reducing blood sugar and application in pharmacy and health food thereof | |
CN108379495A (en) | Galangal rhizome extract is preparing the purposes in preventing and/or treating nonalcoholic fatty liver preparation | |
CN108853308A (en) | A kind of Chinese paris rhizome total saponin-semen momordicae pharmaceutical composition and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120627 Termination date: 20171226 |
|
CF01 | Termination of patent right due to non-payment of annual fee |